WHO grade III

WHO grade III tumors are malignant and often recur as higher grade tumors (WHO grade IV).


Grade 3 astrocytomas are considered to be malignant or anaplastic. They show more abnormal cell characteristics and are faster-growing than lower-grade tumors but are not as aggressive as Grade 4 tumors.


Anaplasia, significant mitotic activity

No necrosis or microvascular proliferation

CDKN2A/B homozygous deletion absent


Hong et al. found significant differences in MRI features, including volumetrics, CBV, and ADC, in G3 gliomas, according to IDH mutation and 1p/19q co-deletion status, which can be utilized for the prediction of genomic profiles and the prognosis of G3 glioma patients. The MRI signatures and prognosis of IDH-wildtype glioma G3 gliomas tend to follow those of Glioblastoma IDH wildtype 1).

WHO grade III astrocytoma


1)
Hong EK, Choi SH, Shin DJ, et al. Comparison of Genetic Profiles and Prognosis of High-Grade Gliomas Using Quantitative and Qualitative MRI Features: A Focus on G3 Gliomas [published online ahead of print, 2020 Sep 10]. Korean J Radiol. 2020;10.3348/kjr.2020.0011. doi:10.3348/kjr.2020.0011
  • who_grade_iii.txt
  • Last modified: 2024/06/07 02:58
  • by 127.0.0.1